Today: 19 March 2026
Subscribe
Browse Category

ASX:PME 24 November 2025 - 6 March 2026

Why Pro Medicus (ASX:PME) shares jumped 4.6% today

Why Pro Medicus (ASX:PME) shares jumped 4.6% today

Pro Medicus shares jumped 4.6% to A$121.49 on Thursday, valuing the company at about A$12.1 billion. The stock remains down 53% over the past year despite recent gains. Interim results showed revenue up 28.4% to A$124.8 million, with profit boosted by a large fair value gain on a 4D Medical investment. An on-market buyback is underway through March 2026.
5 March 2026
··
ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech

ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech

ASX 200 futures traded around 8,988 early Tuesday, about 0.4% below Monday’s close after the index fell 0.61% on U.S. tariff uncertainty. Growth stocks and banks dropped, while resources and gold miners outperformed. The Australian dollar slipped 0.2% to 70.68 U.S. cents. Traders await January inflation data due Wednesday.
23 February 2026
········
ASX 200 Today: Index Rebounds From Near Six‑Month Low as Banks, Miners Lift the Market – 24 November 2025

ASX 200 Today: Index Rebounds From Near Six‑Month Low as Banks, Miners Lift the Market – 24 November 2025

The S&P/ASX 200 rose about 1.1% to 8,507 by late morning Monday, rebounding after a 1.6% drop Friday that erased nearly $40 billion in value. All major sectors traded higher, led by financials and industrials. The index remains roughly 7–8% below its October record high, following four straight weekly losses. Investors await a key inflation report due Wednesday.
24 November 2025
·····

Stock Market Today

  • U.S. Gold (USAU) Valuation Reviewed Amid Recent Share Price Decline
    March 19, 2026, 11:10 AM EDT. U.S. Gold (USAU) shares have declined sharply, down 6.8% in one day and 16.7% year to date, drawing attention to its valuation. Trading at $15.40 versus an analyst target of $30.60, the stock shows a price-to-book (P/B) ratio of 4.8x, lower than its peer average of 9.3x but above the broader mining sector average of 2.2x. Despite no current revenue and a net loss of $19.6 million, its 1-year total shareholder return stands at 49.5%. A discounted cash flow (DCF) model estimates a fair value of $565.69, suggesting the shares may be undervalued. The disparity between valuation methods highlights risks tied to funding and execution but also potential upside for this early-stage explorer.
Go toTop